Adalat and Serum ferritin increased - a phase IV clinical study of FDA data

Summary:

Serum ferritin increased is reported as a side effect among people who take Adalat (nifedipine), especially for people who are male, 40-49 old, have been taking the drug for < 1 month also take Norvasc, and have Hyperphosphataemia.

The phase IV clinical study analyzes which people have Serum ferritin increased when taking Adalat. It is created by eHealthMe based on reports of 20,643 people who have side effects when taking Adalat from the FDA, and is updated regularly.

What is Adalat?

Adalat has active ingredients of nifedipine. It is often used in high blood pressure. eHealthMe is studying from 20,940 Adalat users. Check the latest studies of Adalat.

What is Serum ferritin increased?

Serum ferritin increased is found to be associated with 615 drugs and 844 conditions by eHealthMe. Check the latest studies of Serum ferritin increased.

On Jul, 26, 2026

20,643 people reported to have side effects when taking Adalat.
Among them, 28 people (0.14%) have Serum ferritin increased.

Could Adalat cause Serum ferritin increased?

Among these 28 people:

How long have people been on Adalat when they have Serum ferritin increased? *

What is the gender of people who have Serum ferritin increased when taking Adalat? *

female: 17.86 %
male: 82.14 %

What is the age of people who have Serum ferritin increased when taking Adalat? *

What are other drugs people take besides Adalat? *

What are other side effects people have besides Serum ferritin increased? *

Hyperkalemia (damage to or disease of the kidney): 15 people, 53.57%
Sinus Tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node): 13 people, 46.43%
Dehydration (dryness resulting from the removal of water): 13 people, 46.43%
Respiratory Depression (respiration has a rate below 12 breaths): 13 people, 46.43%
Depression: 13 people, 46.43%
Weakness: 13 people, 46.43%
Confusional State: 13 people, 46.43%
Drug Withdrawal Syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation): 13 people, 46.43%
Testicular Pain (pain in testes): 12 people, 42.86%
Headache (pain in head): 12 people, 42.86%

What are the existing conditions these people have? *

Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood): 7 people, 25.00%
Pain: 3 people, 10.71%
Chronic Kidney Disease: 3 people, 10.71%
Primary Myelofibrosis (primary disorder of the bone marrow): 2 people, 7.14%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 2 people, 7.14%
Gastric Ulcer (stomach ulcer): 2 people, 7.14%
Diabetes: 2 people, 7.14%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 3.57%
Refractory Anaemia With An Excess Of Blasts (one or more cell types are low in the blood and look abnormal in the bone marrow): 1 person, 3.57%
Iron Overload: 1 person, 3.57%

* Approximation only. Some reports may have incomplete information.

Do you take Adalat and have Serum ferritin increased?

- Check whether Serum ferritin increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Adalat:

Adalat (20,940 reports)

Browse all side effects of Adalat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Serum ferritin increased:

Serum ferritin increased (615 drugs)

Browse all the conditions that are associated with Serum ferritin increased:

Serum ferritin increased (844 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nifedipine (the active ingredients of Adalat) and Adalat (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.